Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nuclear Medicine Therapy Market Growth (Status and Outlook) 2022-2028

  • LP 4886041
  • 103 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Nuclear Medicine Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Nuclear Medicine Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nuclear Medicine Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Nuclear Medicine Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nuclear Medicine Therapy market, reaching US$ million by the year 2028. As for the Europe Nuclear Medicine Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Nuclear Medicine Therapy players cover Novartis, Bayer, China Isotope & Radiation, and Q BioMed, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Radium-223

Lutetium-177

Iodine-131

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Thyroid

Bone Metastasis

Lymphoma

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Novartis

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nuclear Medicine Therapy Market Size 2017-2028

2.1.2 Nuclear Medicine Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Nuclear Medicine Therapy Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Nuclear Medicine Therapy Market Size by Type

2.3.1 Nuclear Medicine Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

2.4 Nuclear Medicine Therapy Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Nuclear Medicine Therapy Market Size by Application

2.5.1 Nuclear Medicine Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

3 Nuclear Medicine Therapy Market Size by Player

3.1 Nuclear Medicine Therapy Market Size Market Share by Players

3.1.1 Global Nuclear Medicine Therapy Revenue by Players (2020-2022)

3.1.2 Global Nuclear Medicine Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Nuclear Medicine Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Nuclear Medicine Therapy by Regions

4.1 Nuclear Medicine Therapy Market Size by Regions (2017-2022)

4.2 Americas Nuclear Medicine Therapy Market Size Growth (2017-2022)

4.3 APAC Nuclear Medicine Therapy Market Size Growth (2017-2022)

4.4 Europe Nuclear Medicine Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Nuclear Medicine Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Nuclear Medicine Therapy Market Size by Country (2017-2022)

5.2 Americas Nuclear Medicine Therapy Market Size by Type (2017-2022)

5.3 Americas Nuclear Medicine Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nuclear Medicine Therapy Market Size by Region (2017-2022)

6.2 APAC Nuclear Medicine Therapy Market Size by Type (2017-2022)

6.3 APAC Nuclear Medicine Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Nuclear Medicine Therapy by Country (2017-2022)

7.2 Europe Nuclear Medicine Therapy Market Size by Type (2017-2022)

7.3 Europe Nuclear Medicine Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nuclear Medicine Therapy by Region (2017-2022)

8.2 Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Nuclear Medicine Therapy Market Forecast

10.1 Global Nuclear Medicine Therapy Forecast by Regions (2023-2028)

10.1.1 Global Nuclear Medicine Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Nuclear Medicine Therapy Forecast

10.1.3 APAC Nuclear Medicine Therapy Forecast

10.1.4 Europe Nuclear Medicine Therapy Forecast

10.1.5 Middle East & Africa Nuclear Medicine Therapy Forecast

10.2 Americas Nuclear Medicine Therapy Forecast by Country (2023-2028)

10.2.1 United States Nuclear Medicine Therapy Market Forecast

10.2.2 Canada Nuclear Medicine Therapy Market Forecast

10.2.3 Mexico Nuclear Medicine Therapy Market Forecast

10.2.4 Brazil Nuclear Medicine Therapy Market Forecast

10.3 APAC Nuclear Medicine Therapy Forecast by Region (2023-2028)

10.3.1 China Nuclear Medicine Therapy Market Forecast

10.3.2 Japan Nuclear Medicine Therapy Market Forecast

10.3.3 Korea Nuclear Medicine Therapy Market Forecast

10.3.4 Southeast Asia Nuclear Medicine Therapy Market Forecast

10.3.5 India Nuclear Medicine Therapy Market Forecast

10.3.6 Australia Nuclear Medicine Therapy Market Forecast

10.4 Europe Nuclear Medicine Therapy Forecast by Country (2023-2028)

10.4.1 Germany Nuclear Medicine Therapy Market Forecast

10.4.2 France Nuclear Medicine Therapy Market Forecast

10.4.3 UK Nuclear Medicine Therapy Market Forecast

10.4.4 Italy Nuclear Medicine Therapy Market Forecast

10.4.5 Russia Nuclear Medicine Therapy Market Forecast

10.5 Middle East & Africa Nuclear Medicine Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Nuclear Medicine Therapy Market Forecast

10.5.2 South Africa Nuclear Medicine Therapy Market Forecast

10.5.3 Israel Nuclear Medicine Therapy Market Forecast

10.5.4 Turkey Nuclear Medicine Therapy Market Forecast

10.5.5 GCC Countries Nuclear Medicine Therapy Market Forecast

10.6 Global Nuclear Medicine Therapy Forecast by Type (2023-2028)

10.7 Global Nuclear Medicine Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Nuclear Medicine Therapy Product Offered

11.1.3 Novartis Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis Main Business Overview

11.1.5 Novartis Latest Developments

11.2 Bayer

11.2.1 Bayer Company Information

11.2.2 Bayer Nuclear Medicine Therapy Product Offered

11.2.3 Bayer Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bayer Main Business Overview

11.2.5 Bayer Latest Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Nuclear Medicine Therapy Product Offered

11.3.3 China Isotope & Radiation Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 China Isotope & Radiation Main Business Overview

11.3.5 China Isotope & Radiation Latest Developments

11.4 Q BioMed

11.4.1 Q BioMed Company Information

11.4.2 Q BioMed Nuclear Medicine Therapy Product Offered

11.4.3 Q BioMed Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Q BioMed Main Business Overview

11.4.5 Q BioMed Latest Developments

11.5 Curium Pharmaceuticals

11.5.1 Curium Pharmaceuticals Company Information

11.5.2 Curium Pharmaceuticals Nuclear Medicine Therapy Product Offered

11.5.3 Curium Pharmaceuticals Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Curium Pharmaceuticals Main Business Overview

11.5.5 Curium Pharmaceuticals Latest Developments

11.6 Jubilant DraxImage

11.6.1 Jubilant DraxImage Company Information

11.6.2 Jubilant DraxImage Nuclear Medicine Therapy Product Offered

11.6.3 Jubilant DraxImage Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Jubilant DraxImage Main Business Overview

11.6.5 Jubilant DraxImage Latest Developments

11.7 Dongcheng

11.7.1 Dongcheng Company Information

11.7.2 Dongcheng Nuclear Medicine Therapy Product Offered

11.7.3 Dongcheng Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Dongcheng Main Business Overview

11.7.5 Dongcheng Latest Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Nuclear Medicine Therapy Product Offered

11.8.3 Lantheus Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lantheus Main Business Overview

11.8.5 Lantheus Latest Developments

11.9 Acrotech Biopharma.

11.9.1 Acrotech Biopharma. Company Information

11.9.2 Acrotech Biopharma. Nuclear Medicine Therapy Product Offered

11.9.3 Acrotech Biopharma. Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Acrotech Biopharma. Main Business Overview

11.9.5 Acrotech Biopharma. Latest Developments

11.10 Progenics Pharmaceuticals

11.10.1 Progenics Pharmaceuticals Company Information

11.10.2 Progenics Pharmaceuticals Nuclear Medicine Therapy Product Offered

11.10.3 Progenics Pharmaceuticals Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Progenics Pharmaceuticals Main Business Overview

11.10.5 Progenics Pharmaceuticals Latest Developments

11.11 International Isotopes

11.11.1 International Isotopes Company Information

11.11.2 International Isotopes Nuclear Medicine Therapy Product Offered

11.11.3 International Isotopes Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 International Isotopes Main Business Overview

11.11.5 International Isotopes Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Nuclear Medicine Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Radium-223

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Iodine-131

Table 5. Major Players of Other

Table 6. Nuclear Medicine Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Nuclear Medicine Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

Table 9. Nuclear Medicine Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Nuclear Medicine Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

Table 12. Global Nuclear Medicine Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Nuclear Medicine Therapy Revenue Market Share by Player (2020-2022)

Table 14. Nuclear Medicine Therapy Key Players Head office and Products Offered

Table 15. Nuclear Medicine Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Nuclear Medicine Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Nuclear Medicine Therapy Market Size Market Share by Regions (2017-2022)

Table 20. Americas Nuclear Medicine Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Nuclear Medicine Therapy Market Size Market Share by Country (2017-2022)

Table 22. Americas Nuclear Medicine Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

Table 24. Americas Nuclear Medicine Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

Table 26. APAC Nuclear Medicine Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Nuclear Medicine Therapy Market Size Market Share by Region (2017-2022)

Table 28. APAC Nuclear Medicine Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

Table 30. APAC Nuclear Medicine Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

Table 32. Europe Nuclear Medicine Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Nuclear Medicine Therapy Market Size Market Share by Country (2017-2022)

Table 34. Europe Nuclear Medicine Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

Table 36. Europe Nuclear Medicine Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Nuclear Medicine Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Nuclear Medicine Therapy

Table 45. Key Market Challenges & Risks of Nuclear Medicine Therapy

Table 46. Key Industry Trends of Nuclear Medicine Therapy

Table 47. Global Nuclear Medicine Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Nuclear Medicine Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Nuclear Medicine Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Nuclear Medicine Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Nuclear Medicine Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Nuclear Medicine Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 53. Novartis Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 54. Novartis Nuclear Medicine Therapy Product Offered

Table 55. Novartis Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Novartis Main Business

Table 57. Novartis Latest Developments

Table 58. Bayer Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 59. Bayer Nuclear Medicine Therapy Product Offered

Table 60. Bayer Main Business

Table 61. Bayer Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Bayer Latest Developments

Table 63. China Isotope & Radiation Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 64. China Isotope & Radiation Nuclear Medicine Therapy Product Offered

Table 65. China Isotope & Radiation Main Business

Table 66. China Isotope & Radiation Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. China Isotope & Radiation Latest Developments

Table 68. Q BioMed Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 69. Q BioMed Nuclear Medicine Therapy Product Offered

Table 70. Q BioMed Main Business

Table 71. Q BioMed Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Q BioMed Latest Developments

Table 73. Curium Pharmaceuticals Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 74. Curium Pharmaceuticals Nuclear Medicine Therapy Product Offered

Table 75. Curium Pharmaceuticals Main Business

Table 76. Curium Pharmaceuticals Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Curium Pharmaceuticals Latest Developments

Table 78. Jubilant DraxImage Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 79. Jubilant DraxImage Nuclear Medicine Therapy Product Offered

Table 80. Jubilant DraxImage Main Business

Table 81. Jubilant DraxImage Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Jubilant DraxImage Latest Developments

Table 83. Dongcheng Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 84. Dongcheng Nuclear Medicine Therapy Product Offered

Table 85. Dongcheng Main Business

Table 86. Dongcheng Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Dongcheng Latest Developments

Table 88. Lantheus Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 89. Lantheus Nuclear Medicine Therapy Product Offered

Table 90. Lantheus Main Business

Table 91. Lantheus Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Lantheus Latest Developments

Table 93. Acrotech Biopharma. Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 94. Acrotech Biopharma. Nuclear Medicine Therapy Product Offered

Table 95. Acrotech Biopharma. Main Business

Table 96. Acrotech Biopharma. Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Acrotech Biopharma. Latest Developments

Table 98. Progenics Pharmaceuticals Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 99. Progenics Pharmaceuticals Nuclear Medicine Therapy Product Offered

Table 100. Progenics Pharmaceuticals Main Business

Table 101. Progenics Pharmaceuticals Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Progenics Pharmaceuticals Latest Developments

Table 103. International Isotopes Details, Company Type, Nuclear Medicine Therapy Area Served and Its Competitors

Table 104. International Isotopes Nuclear Medicine Therapy Product Offered

Table 105. International Isotopes Nuclear Medicine Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. International Isotopes Main Business

Table 107. International Isotopes Latest Developments

List of Figures

Figure 1. Nuclear Medicine Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Nuclear Medicine Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Nuclear Medicine Therapy Market Size Market Share by Type in 2021

Figure 7. Nuclear Medicine Therapy in Thyroid

Figure 8. Global Nuclear Medicine Therapy Market: Thyroid (2017-2022) & ($ Millions)

Figure 9. Nuclear Medicine Therapy in Bone Metastasis

Figure 10. Global Nuclear Medicine Therapy Market: Bone Metastasis (2017-2022) & ($ Millions)

Figure 11. Nuclear Medicine Therapy in Lymphoma

Figure 12. Global Nuclear Medicine Therapy Market: Lymphoma (2017-2022) & ($ Millions)

Figure 13. Nuclear Medicine Therapy in Other

Figure 14. Global Nuclear Medicine Therapy Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Nuclear Medicine Therapy Market Size Market Share by Application in 2021

Figure 16. Global Nuclear Medicine Therapy Revenue Market Share by Player in 2021

Figure 17. Global Nuclear Medicine Therapy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Nuclear Medicine Therapy Market Size 2017-2022 ($ Millions)

Figure 19. APAC Nuclear Medicine Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Europe Nuclear Medicine Therapy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Nuclear Medicine Therapy Market Size 2017-2022 ($ Millions)

Figure 22. Americas Nuclear Medicine Therapy Value Market Share by Country in 2021

Figure 23. Americas Nuclear Medicine Therapy Consumption Market Share by Type in 2021

Figure 24. Americas Nuclear Medicine Therapy Market Size Market Share by Application in 2021

Figure 25. United States Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Nuclear Medicine Therapy Market Size Market Share by Region in 2021

Figure 30. APAC Nuclear Medicine Therapy Market Size Market Share by Application in 2021

Figure 31. China Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Nuclear Medicine Therapy Market Size Market Share by Country in 2021

Figure 38. Europe Nuclear Medicine Therapy Market Size Market Share by Type in 2021

Figure 39. Europe Nuclear Medicine Therapy Market Size Market Share by Application in 2021

Figure 40. Germany Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Nuclear Medicine Therapy Market Size Market Share by Application in 2021

Figure 48. Egypt Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Nuclear Medicine Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 54. APAC Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 55. Europe Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 57. United States Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Canada Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 61. China Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Japan Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Korea Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 65. India Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Australia Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Germany Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 68. France Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 69. UK Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Italy Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Russia Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Spain Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Israel Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Nuclear Medicine Therapy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390